Alzamend Neuro, Inc. Net Income Loss

• Alzamend Neuro, Inc. showed an increase of +54.6% in Net Income Loss from 2024 to 2025.
• This data is from Alzamend Neuro, Inc.'s annual report (Form 10-K), filed with the SEC on July 22, 2025.
• XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 6 years of available data (2020 to 2025), Alzamend Neuro, Inc.'s Net Income Loss has declined by 2.4%.
• Historical annual values: Fiscal year 2025: -$4.51 million | Fiscal year 2024: -$9.95 million | Fiscal year 2023: -$14.88 million | Fiscal year 2022: -$12.36 million | Fiscal year 2021: -$5.05 million | Fiscal year 2020: -$4.41 million.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026